Balaxi Pharmaceuticals NSE
464.45 00.00 (1.04%)
Balaxi Pharmaceuticals share price as of last closing was 464.45 on . As on date, the market capitalization of the company is Rs. 476.47 Crores and the book value of the same is Rs 82.13 Crores. As per NSE data, in last traded details the quantity of shares traded for Balaxi Pharmaceuticals were . For the last 1 year period, Balaxi Pharmaceuticals share price saw 1-year high of 706.00 and 1-year low of 435.45. If you would have invested in Balaxi Pharmaceuticals share,... based on its share price your 1-year return on same would be 6.00%, on a 3-year investment period the return would be 39.86% and on a 5 year investment period the return would be 1522.82%. In the financial year fy_overview, Balaxi Pharmaceuticals registered a net income of net_income_overview. The company’s EPS stood at eps_overview while P/E Ratio stood at 34.02. While, analysing Share Price of a company is crucial, it is equally important to look at the Stock Performance, Fundamental Analysis, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
Markets Today
High | 469.50 |
Open at | 466.00 |
Volumes | 1031 |
Lower Circuit | 2100.00 |
Low | 465.00 |
Prev Close | 464.45 |
Avg Price | 2205.85 |
Upper Circuit | 2400.00 |
Last Traded Details
Quantity | 92,923 |
Time | 13:46:05 |
Historical Performance
1-Year High | 706.00 |
3-Year High | 1080.20 |
5-Year High | 1080.20 |
1-Year Low | 435.45 |
3-Year Low | 300.55 |
5-Year Low | 27.10 |
1-Year Performance Indicator
Company Valuation
Market Cap (₹ Cr.) | 476.47 |
Book Value (₹) | 82.13 |
Face Value (₹) | 10.00 |
P/E ratio | 34.02 |
Dividend Yield | 0.11 % |
Income Statements
In Short term
In Long term
1 Week | -0.96% |
1 Month | -11.03% |
3 Months | -23.90% |
6 Months | -12.06% |
9 Months | -21.09% |
1 Year | 6.00% |
2 Years | -12.77% |
3 Years | 39.86% |
4 Years | 467.64% |
5 Years | 1522.82% |
Balaxi Pharmaceuticals share price as of today is Rs. . The company has a market capitalization of Rs. 476.47 with a P/E ratio of 34.02. Over the past 1 year, Balaxi Pharmaceuticals’s share price has moved by 6.00% while the 5-year performance of the stock stands at 1522.82%. You’d also be interested to know that Balaxi Pharmaceuticals's share price has a 1-year low of ₹ 435.45 and a 1-year high of ₹ 706.00.
The Balaxi Pharmaceuticals share hit a 1-year low of Rs. 435.45 and a 1-year high of Rs. 706.00. The current market capitalization of Balaxi Pharmaceuticals is Rs. 476.47. While past performance does not guarantee future performance, the past 1-year return of Balaxi Pharmaceuticals share was 6.00% while the 5-year return was 1522.82%.
Balaxi Pharmaceuticals share price has moved by 6.00% in the past 1 year. During the same time, the stock hit a 1-year high of Rs. 706.00 and a 1-year low of Rs. 435.45. As far as the long-term trend is concerned, the 5-year performance of Balaxi Pharmaceuticals share stands at 1522.82%
Balaxi Pharmaceuticals has a market capitalization of Rs. 476.47 as of today, while the share price stands at . The market cap has moved by 6.00% in the past year and 1522.82% in the past 5 years.
As a stock investor, you’d be interested in knowing that Balaxi Pharmaceuticals share price has a P/E ratio of 34.02 as of today. Along with the P/E ratio, the book value of Balaxi Pharmaceuticals’s stock is Rs. 82.13
Domestic Institutional Investors (DIIs) have a share in Balaxi Pharmaceuticals whereas Foreign Institutional Investors (FIIs) hold . The split between DIIs and FIIs is a crucial metric that stock investors track to gauge the market sentiment around the stock. The company’s promoters own of Balaxi Pharmaceuticals while non-promoters have a stake.
You can buy Balaxi Pharmaceuticals shares using the Dhan Trading App or Web Trading Platform. Follow these steps to get started:
If you have little money and want to buy Balaxi Pharmaceuticals stocks,Margin Trading Facility (MTF) is just the thing you need! MTF allows you to buy more with less. In fact, you can buy up to 4x more, which means you pay 25% and Dhan pays 75% for buying Balaxi Pharmaceuticals stocks.